Irvine Scientific says it will build a media R&D lab at its Orange County site
Irvine Scientific has announced plans for an R&D centre at its site in Irvine, California citing increasing biopharma industry demand for cell culture and media regents.
Irvine Scientific has announced plans for an R&D centre at its site in Irvine, California citing increasing biopharma industry demand for cell culture and media regents.
Thermo Fisher has opened a UK test centre to allow biopharmaceutical industry customers to test single-use production technologies.
JSR Life Sciences has agreed to buy cell line developer Selexis SA.
Merck & Co has halted two Phase III studies examining its drug Keytruda (pembrolizumab) in combination with other therapies after reports of patient deaths.